{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "46122-598",
      "generic_name": "Aspirin",
      "labeler_name": "Amerisource Bergen",
      "brand_name": "Aspirin 81",
      "active_ingredients": [
        {
          "name": "ASPIRIN",
          "strength": "81 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "46122-598-48",
          "description": "1 BOTTLE, PLASTIC in 1 CARTON (46122-598-48)  / 180 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC",
          "marketing_start_date": "20190531",
          "sample": false
        },
        {
          "package_ndc": "46122-598-87",
          "description": "300 TABLET, DELAYED RELEASE in 1 BOTTLE, PLASTIC (46122-598-87)",
          "marketing_start_date": "20190531",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Amerisource Bergen"
        ],
        "rxcui": [
          "308416"
        ],
        "spl_set_id": [
          "4491faca-f30b-4eb0-bea9-f518f6b2f095"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0346122598484"
        ],
        "nui": [
          "N0000000160",
          "N0000008836",
          "M0001335",
          "N0000175722",
          "N0000175578",
          "N0000008832"
        ],
        "pharm_class_moa": [
          "Cyclooxygenase Inhibitors [MoA]"
        ],
        "pharm_class_pe": [
          "Decreased Prostaglandin Production [PE]",
          "Decreased Platelet Aggregation [PE]"
        ],
        "pharm_class_cs": [
          "Anti-Inflammatory Agents, Non-Steroidal [CS]"
        ],
        "pharm_class_epc": [
          "Nonsteroidal Anti-inflammatory Drug [EPC]",
          "Platelet Aggregation Inhibitor [EPC]"
        ],
        "unii": [
          "R16CO5Y76E"
        ]
      },
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "TABLET, DELAYED RELEASE",
      "spl_id": "e45943bf-ed89-49bd-bc1f-364afdb04e77",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20190531",
      "product_id": "46122-598_e45943bf-ed89-49bd-bc1f-364afdb04e77",
      "application_number": "M013",
      "brand_name_base": "Aspirin 81",
      "pharm_class": [
        "Anti-Inflammatory Agents",
        "Non-Steroidal [CS]",
        "Cyclooxygenase Inhibitors [MoA]",
        "Decreased Platelet Aggregation [PE]",
        "Decreased Prostaglandin Production [PE]",
        "Nonsteroidal Anti-inflammatory Drug [EPC]",
        "Platelet Aggregation Inhibitor [EPC]"
      ]
    }
  ]
}